Search filters

List of works by Steven Le Gouill

Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials ⬇️

scientific article published on November 1, 2003

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

scientific article published on 01 August 2018

Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?

scientific article published on 5 June 2009

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.

scientific article published on 16 August 2013

BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment

scientific article published on 11 October 2018

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era

scientific article published on 30 January 2020

Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma

scientific article published on 19 August 2004

Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity ⬇️

scientific article published on November 28, 2011

Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography

scientific article published on 11 February 2008

FDG-PET in Follicular Lymphoma Management ⬇️

scientific article published on July 30, 2012

Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria.

scientific article published on 2 December 2013

High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphoma

scientific article published on 12 July 2010

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of

scientific article published on 27 October 2008

Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis

scientific article

Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

scientific article

Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma

scientific article

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

scientific article published on 01 September 2018

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

scientific article published on 03 May 2013

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study

scientific article published on 05 October 2018

Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.

scientific article published on 29 April 2010

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

scientific article published on 01 August 2019

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

scientific article published in September 2017

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

scientific article published on 01 September 2018

Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.

scientific article published on 27 November 2017

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.

scientific article published on 25 August 2010

VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis

scientific article published on 24 June 2004

Paulina is supported by:

About Paulina

Help